Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Gary Burton who wrote (649)	12/23/1997 6:09:00 PM
From: Thomas Haegin	Respond to of 2068

Gary, I agree. I continue to stand-by only. That's my 2c <g>. -Tom -e-

To: Gary Burton who wrote (649)	12/23/1997 7:43:00 PM
From: Stephen M. DeMoss	Read Replies (1) \| Respond to of 2068

Gary, Why do you think that S&P has Oxhp in their Platinum portfolio for 1998? They have the stock fairly priced at 56.80 with a Pe of 10 and estimated 98 earnings of 1.40. Who, if either, should we have confidense with? My wife is a hospital administrator and says Oxford will be bought out if it continues to lanquish here, that they have a very workable system of delivery, and in January enrollment will be going up despite uncertainties on bookeeping and insider trading. She says buy. I have been holding off because of the general weakness in our markets and the big uncertainties overseas and the pre-announcements/general downtrend in the Hmo stocks. I would like to enter after Oxhp bases. Are you saying in your humble opinion that that is a mistake? Ps. Are you the Gary Burton from the Aplx thread? Thanks in advance, Steve D.